摘要
2019年12月底在武汉爆发不明原因肺炎(后证实病原体为新型冠状病毒),而后引起全国范围的暴发,目前为止已有多个国家发现数量不等的感染,严重危害人们的生命健康。我国卫健委1号公告将新型冠状病毒感染的肺炎纳入《传染病防治法》规定的乙类传染病,并采取甲类传染病的预防、控制措施。目前对新型冠状病毒肺炎的治疗仍处于探索阶段,本文对新型冠状病毒肺炎的治疗进展进行汇总,为后续治疗探索提供参考。
In the end of December 2019,an unexplained pneumonia outbroke in Wuhan(the pathogen later confirmed to be novel coronavirus),and then caused a nationwide outbreak,varying quantity of infections have be found in several countries,which cause serious damage to people’s lives and health.National Health Committee of the People’s Republic of China published Announcement of the National Health Committee of the People’s Republic of China No.1 of 2020,what Coronavirus Disease 2019(COVID-19)was included in the management of Class B infectious diseases,and measures for the prevention and control of Class A Infectious Diseases should be taken according to the Law on the Prevention and Control of Infectious Diseases.The treatment for COVID-19 is still in exploration,in order to provide reference for subsequent treatment,we will summarize the progress of the therapy in this paper.
作者
张梦月
杨炯
ZHANG Mengyue;YANG Jiong(Dept.of Respiratory and Critical Care Medicine,Zhongnan Hospital of Wuhan University,Wuhan 430071,Hubei,China)
出处
《武汉大学学报（医学版）》
CAS
2020年第4期555-559,共5页
Medical Journal of Wuhan University
作者简介
张梦月,女,1994-,医学硕士生,主要从事呼吸系统疾病研究,E-mail:2018283030106@whu.edu.cn;通讯作者:杨炯,男,1956-,医学博士,教授,博士生导师,主要从事呼吸系统疾病研究,E-mail:yangjiongwh@126.com
